Dr. Cross is a Reader in Cancer Epidemiology in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group (http://csprg.org.uk) in the Department of Surgery and Cancer at Imperial.
She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut. Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.
Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk. She currently leads the Cancer Prevention and Early Detection theme in the Cancer Research UK centre at Imperial. In addition to her research commitments, she is co-Director of the MSc in Epidemiology at Imperial College.
et al., 2019, Consumption of Meat, Fish, Dairy Products, Eggs and Risk of Ischemic Heart Disease: A Prospective Study of 7198 Incident Cases Among 409,885 Participants in the Pan-European EPIC Cohort., Circulation
et al., 2019, Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies., Gut, Vol:68, Pages:672-683
et al., 2019, Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening, Journal of Medical Screening, Vol:26, ISSN:0969-1413, Pages:11-18
et al., 2019, Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer, Annals of Oncology, ISSN:0923-7534
et al., 2019, Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study, British Journal of Cancer, Vol:120, ISSN:0007-0920, Pages:154-164